New Immunotherapies Bring Hope to Patients with Rare Liver Cancers Tina lived a healthy lifestyle and wanted to live as long as she could. A rare cancer diagnosis called cholangiocarcinoma threatened her dreams. Tina’s oncologist recommended a clinical trial that combined chemotherapy and immunotherapy. She details how the treatment extended her life and why patients must advocate for themselves. Read more: Post navigation The CRISPR Revolution: How Genomic Engineering is Transforming Cancer Immunotherapy Read Story CICON Landing Page Draft Read Story